 | Up a level |
Armario, Xavier; Carron, Jennifer; Simpkin, Andrew J; Elhadi, Mohamed; Kennedy, Ciara; Abdel-Wahab, Mohamed; Bleiziffer, Sabine; Lefèvre, Thierry; Wolf, Alexander; Pilgrim, Thomas; Villablanca, Pedro A; Blackman, Daniel J; Van Mieghem, Nicolas M; Hengstenberg, Christian; Swaans, Martin J; Prendergast, Bernard D; Patterson, Tiffany; Barbanti, Marco; Webb, John G; Behan, Miles; ... (2024). Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study. JACC. Cardiovascular Interventions, 17(3), pp. 374-387. Elsevier 10.1016/j.jcin.2023.10.041
Yamamoto, Masanori; Hayashida, Kentaro; Hengstenberg, Christian; Watanabe, Yusuke; Van Mieghem, Nicolas M; Jin, James; Saito, Shigeru; Valgimigli, Marco; Nicolas, Johny; Mehran, Roxana; Moreno, Raul; Kimura, Tetsuya; Chen, Cathy; Unverdorben, Martin; Dangas, George D (2023). Predictors of All-Cause Mortality After Successful Transcatheter Aortic Valve Implantation in Patients With Atrial Fibrillation. The American journal of cardiology, 207, pp. 150-158. Elsevier 10.1016/j.amjcard.2023.08.067
Van Mieghem, Nicolas M; Unverdorben, Martin; Hengstenberg, Christian; Möllmann, Helge; Mehran, Roxana; López-Otero, Diego; Nombela-Franco, Luis; Moreno, Raul; Nordbeck, Peter; Thiele, Holger; Lang, Irene; Zamorano, José L; Shawl, Fayaz; Yamamoto, Masanori; Watanabe, Yusuke; Hayashida, Kentaro; Hambrecht, Rainer; Meincke, Felix; Vranckx, Pascal; Jin, James; ... (2021). Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. The New England journal of medicine, 385(23), pp. 2150-2160. Massachusetts Medical Society 10.1056/NEJMoa2111016
